Results 141 to 150 of about 20,096 (225)
Estimating Baseline Survival Function in the Proportional Hazards Model Under Monotone Hazards. [PDF]
Wu Y, Chappell R.
europepmc +1 more source
ABSTRACT Background The benefit of consolidation programmed cell death protein 1 (PD‐1) blockade after chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear. Methods Patients with stages II–IVB NPC were randomized (2:1) to pembrolizumab 200 mg or placebo every 3 weeks for up to 17 cycles after chemoradiotherapy ...
Sang Hoon Chun +11 more
wiley +1 more source
Frequentist and Bayesian Predictive Inference for the Log-Logistic Distribution Under Progressive Type-II Censoring. [PDF]
Zhang Z, Gui W.
europepmc +1 more source
ABSTRACT Background Adenoid cystic carcinoma (ACC) is a rare malignancy with a propensity for perineural invasion and hematogenous spread. Central nervous system (CNS) involvement is uncommon, and detailed clinical and genomic data on this aspect of the disease remain limited.
Omar Elghawy +7 more
wiley +1 more source
Years of life lost in cutaneous squamous cell carcinoma: analysis of a prospective cohort of 1400 patients. [PDF]
Dietz K, Eigentler TK, Breuninger H.
europepmc +1 more source
ABSTRACT Background Locoregional recurrence remains a clinically relevant problem in oral squamous cell carcinoma (OSCC). Whether local, ipsilateral nodal, and contralateral nodal failure represent distinct disease processes with different clinicopathological associations has not been systematically evaluated.
Jannik Ketschau +9 more
wiley +1 more source
First-passage-based boundary estimation in functional data. [PDF]
Kuzu AT, Celik N.
europepmc +1 more source
A Support vector machine-based mixture cure model for mixed case interval censored data. [PDF]
Pal S, Aselisewine W.
europepmc +1 more source
Discrimination performance in illness-death models with interval-censored disease data. [PDF]
Spreafico M +3 more
europepmc +1 more source
Chemotherapy‐induced nausea and vomiting (CINV) remains a significant clinical problem despite modern antiemetics. In particular, antiemetic strategies for emerging cancer therapies lack detailed evaluation. This randomized trial analyzed hourly CINV data for patients with early breast cancer who received either docetaxel plus cyclophosphamide (TC) or ...
Manuel Hörner +16 more
wiley +1 more source

